Analyst picks & changes
(BCHXF)
UBS Securities analyst David Crossen initiated coverage with a "buy" and a 12-18 month price target of
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
(BCHXF)
UBS Securities analyst David Crossen initiated coverage with a "buy" and a 12-18 month price target of